{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:11:32Z","timestamp":1792098692570,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.atherosclerosis.2015.12.012","type":"journal-article","created":{"date-parts":[[2015,12,20]],"date-time":"2015-12-20T09:30:24Z","timestamp":1450603824000},"page":"200-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation"],"prefix":"10.1016","volume":"245","author":[{"given":"Pauline","family":"Afonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Boccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Capeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Caron-Debarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ceb.2006.03.007","article-title":"Nuclear lamins, diseases and aging","volume":"18","author":"Mattout","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib2","doi-asserted-by":"crossref","first-page":"18111","DOI":"10.1073\/pnas.0408558102","article-title":"Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice","volume":"101","author":"Fong","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib3","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/hmg\/ddi326","article-title":"Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition","volume":"14","author":"Glynn","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib4","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1124875","article-title":"A\u00a0protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria","volume":"311","author":"Fong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib6","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4161\/cc.4.12.2202","article-title":"From immature lamin to premature aging: molecular pathways and therapeutic opportunities","volume":"4","author":"Cadinanos","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib7","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin a truncation in Hutchinson-Gilford progeria","volume":"300","author":"De Sandre-Giovannoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature04019","article-title":"Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation","volume":"437","author":"Varela","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/BC.2009.080","article-title":"ZMPSTE24, an integral membrane zinc metalloprotease with a connection to progeroid disorders","volume":"390","author":"Barrowman","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib10","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","article-title":"Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence","volume":"14","author":"Caron","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib11","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/hmg\/ddi158","article-title":"Altered pre-lamin A processing is a common mechanism leading to lipodystrophy","volume":"14","author":"Capanni","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2002-021506","article-title":"A\u00a0new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy","volume":"88","author":"Caux","year":"2003","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/CIRCRESAHA.107.153692","article-title":"Mechanisms of cardiovascular disease in accelerated aging syndromes","volume":"101","author":"Capell","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib14","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/ATVBAHA.110.209460","article-title":"Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging","volume":"30","author":"Olive","year":"2010","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib15","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in\u00a0vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib16","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.109.902056","article-title":"Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging","volume":"121","author":"Ragnauth","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib17","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1161\/CIRCRESAHA.111.300543","article-title":"Prelamin a accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells","volume":"112","author":"Liu","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.carpath.2007.12.011","article-title":"Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study","volume":"18","author":"Micheletti","year":"2009","journal-title":"Cardiovasc. Pathol. Off. J. Soc. Cardiovasc. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib19","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/jac\/dkr206","article-title":"Human immunodeficiency virus infection is associated with accelerated atherosclerosis","volume":"66","author":"Guaraldi","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2012.06.063","article-title":"HIV and coronary heart disease: time for a better understanding","volume":"61","author":"Boccara","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib21","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib22","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.0704212104","article-title":"HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells","volume":"104","author":"Coffinier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2008.07.033","article-title":"HIV-protease inhibitors block the enzymatic activity of purified Ste24p","volume":"374","author":"Hudon","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib24","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1161\/ATVBAHA.110.213603","article-title":"Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin","volume":"30","author":"Lefevre","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2014.08.036","article-title":"Prelamin A accumulation in endothelial cells induces premature senescence and functional impairment","volume":"237","author":"Bonello-Palot","year":"2014","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2015.12.012_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3851\/IMP2752","article-title":"Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin","volume":"19","author":"Auclair","year":"2014","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib27","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.M800021200","article-title":"Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling","volume":"283","author":"Byon","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2015.12.012_bib28","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.3109\/07853890.2012.660498","article-title":"Vascular calcification and hypertension: cause and effect","volume":"44","author":"Kalra","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/ATVBAHA.113.302070","article-title":"Inflammatory, metabolic, and genetic mechanisms of vascular calcification","volume":"34","author":"Demer","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.exger.2009.07.004","article-title":"Microarray analysis of senescent vascular smooth muscle cells: a link to atherosclerosis and vascular calcification","volume":"44","author":"Burton","year":"2009","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.exger.2010.07.005","article-title":"Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells","volume":"45","author":"Burton","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f1654","article-title":"Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis","volume":"346","author":"Kramer","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib33","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/648080","article-title":"Coronary aging in HIV-infected patients","volume":"49","author":"Guaraldi","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/M13-1754","article-title":"Associations between HIV infection and subclinical coronary atherosclerosis","volume":"160","author":"Post","year":"2014","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archinternmed.2010.197","article-title":"Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French hospital database on HIV ANRS cohort CO4","volume":"170","author":"Lang","year":"2010","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D: A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib37","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/jc.2007-0654","article-title":"New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome","volume":"92","author":"Decaudain","year":"2007","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib38","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/jac\/dkt536","article-title":"Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study","volume":"69","author":"Katlama","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib39","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1097\/01.ASN.0000145894.57533.C4","article-title":"Vascular calcification mechanisms","volume":"15","author":"Giachelli","year":"2004","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib40","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1242\/jcs.133314","article-title":"MicroRNA-141-3p plays a role in human mesenchymal stem cell aging by directly targeting ZMPSTE24","volume":"126","author":"Yu","year":"2013","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/dbio.1999.9523","article-title":"The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation","volume":"216","author":"Olsen","year":"1999","journal-title":"Dev. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/COH.0b013e32814b1638","article-title":"Adipocyte dysfunction in response to antiretroviral therapy : clinical, tissue and in-vitro studies","volume":"2","author":"Caron","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib44","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ajpath.2011.07.049","article-title":"LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue","volume":"179","author":"Bereziat","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(03)14069-X","article-title":"LMNA mutations in atypical Werner's syndrome","volume":"362","author":"Chen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib46","first-page":"164","article-title":"Atypical progeroid syndrome \u2013 case report","volume":"78","author":"Todorovic","year":"2012","journal-title":"Horm. Res."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0969-2126(02)00777-3","article-title":"The Ig-like structure of the C-terminal domain of lamin A\/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy","volume":"10","author":"Krimm","year":"2002","journal-title":"Structure"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib48","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1021\/bi020704g","article-title":"The carboxyl-terminal region common to lamins A and C contains a DNA binding domain","volume":"42","author":"Stierle","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib49","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/hmg\/ddt509","article-title":"Deregulation of fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes","volume":"23","author":"Oldenburg","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib50","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/hmg\/ddu728","article-title":"The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy","volume":"24","author":"Vadrot","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib51","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1126\/science.1231513","article-title":"The structural basis of ZMPSTE24-dependent laminopathies","volume":"339","author":"Quigley","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib52","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.1074\/jbc.M709629200","article-title":"A\u00a0potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells","volume":"283","author":"Coffinier","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/QAD.0b013e32835b2ef1","article-title":"Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events","volume":"27","author":"Monforte","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib54","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1468-1293.2011.00917.x","article-title":"Lipid profiles for nevirapine vs. atazanavir\/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naive HIV-1-infected patients (the ARTEN study)","volume":"12","author":"Podzamczer","year":"2011","journal-title":"HIV Med."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.biopha.2012.12.005","article-title":"Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA project)","volume":"67","author":"Menzaghi","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1258\/ijsa.2012.012120","article-title":"Effects of once-daily darunavir\/ritonavir versus lopinavir\/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMIS","volume":"24","author":"Arathoon","year":"2013","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1468-1293.2012.01060.x","article-title":"Final 192-week efficacy and safety of once-daily darunavir\/ritonavir compared with lopinavir\/ritonavir in HIV-1-infected treatment-naive patients in the ARTEMIS trial","volume":"14","author":"Orkin","year":"2013","journal-title":"HIV Med."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib58","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005229","article-title":"Targeting protein prenylation in progeria","volume":"5","author":"Young","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib60","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.111.00226","article-title":"Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension","volume":"61","author":"Bauer","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2015.12.012_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053035","article-title":"HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \u201caging\u201d study","volume":"7","author":"Perrin","year":"2012","journal-title":"PLoS One"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T14:54:17Z","timestamp":1537109657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015302434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":61,"alternative-id":["S0021915015302434"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.12.012","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}